Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2007-08-31
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective, Randomized, Multi-center Clinical Study of Plasma Disc Decompression
NCT00189605
Radiofrequency Nucleoplasty vs Percutaneous Nucleotomy vs Decompression Catheter in Lumbar Disc Herniation
NCT00300898
Targeted Disc Decompression (TDD) for Contained Herniated Lumbar Discs
NCT01429363
Comparison of Interlaminar CT Guided Epidural Platelet Rich Plasma Versus Steroid Injection in Patients With Lumbar Radicular Pain
NCT07036445
A Randomized Trial Comparing SpineJet® Hydrodiscectomy to Open Lumbar Microdiscectomy for Treatment of Lumbar Radiculopathy Due to Disc Herniation
NCT00384007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PDD procedure
Plasma Disc Decompression/Nucleoplasty
Subjects assigned to the PDD Group will be scheduled to receive the plasma disc decompression procedure using the Coblation® method.
Similarly to in Conservative Care group, subjects will be followed-up at 2, 8 weeks, 6 and 12 months (calculated from the date of the PDD procedure). The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.
Conservative Care
Conservative Care (physiotherapy)
Subjects assigned to the Conservative Care Group will be scheduled to receive physical therapy according to standard and customary care locally.
Subjects will be followed-up at 2, 8 weeks, 6 and 12 months . (Calculated from the time of first going through the individual training programme).The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Plasma Disc Decompression/Nucleoplasty
Subjects assigned to the PDD Group will be scheduled to receive the plasma disc decompression procedure using the Coblation® method.
Similarly to in Conservative Care group, subjects will be followed-up at 2, 8 weeks, 6 and 12 months (calculated from the date of the PDD procedure). The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.
Conservative Care (physiotherapy)
Subjects assigned to the Conservative Care Group will be scheduled to receive physical therapy according to standard and customary care locally.
Subjects will be followed-up at 2, 8 weeks, 6 and 12 months . (Calculated from the time of first going through the individual training programme).The follow-up visits will consist of a brief physical examination in the clinic and completion of study questionnaires.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient's age should be at least 18 years old and no more than 65 years old.
3. A VAS score for radicular pain of 50 or greater on a scale of 0 to 100.
4. Radicular pain concordant with image findings (MRI/CT not older than 12 months).
5. Disc height greater or equal to 50% of expected height in the range of a patient's normal anatomic variations and expected changes due to age.
6. Patient signs informed consent.
Exclusion Criteria
2. Patient has a cardiac pacemaker, automatic defibrillator, or any peripheral stimulator leads in the lumbar area.
3. Allergy to contrast media or drugs to be used in the intended procedure.
4. Medical co-morbidities that preclude surgical intervention.
5. Patient is receiving anti-psychotic therapy.
6. Patient is a prisoner.
7. Patient is incapable of understanding or responding to the study questionnaires.
8. History of previous spinal surgery at, or directly adjacent to, the level to be treated.
9. Patient is morbidly obese (BMI ≥ 40).
10. Patient is simultaneously participating in another device or drug study related to limb/axial pain.
11. Patient has a spinal fracture, tumor or infection.
12. Radicular pain originating from more than one disc level.
13. Axial (back) pain greater than radicular (leg) pain.
14. Clinical evidence of cauda equina syndrome.
15. Progressive neurologic deficit.
16. Radiological evidence of spondylolisthesis at the level to be treated.
17. Radiological evidence of moderate/severe stenosis at the level to be treated.
18. Evidence of extruded or sequestered disc herniation on magnetic resonance imaging.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ArthroCare Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Raahe Hospital
Raahe, , Finland
Storängskliniken
Stockholm, , Sweden
Pallium Reseach Group; Pain Management, L Ward Seacroft Hospital
Leeds, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PDDCC-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.